Technology Platforms

Amneal’s product pipeline represents a diversified range of products across multiple therapeutic areas and dosage forms, including a sizable proportion of complex, high barrier-to-entry and difficult to formulate products. It has eight proprietary research and development facilities located in New York, New Jersey and India, focusing on several product categories in various stages of development. The company’s portfolio now includes more than 100 U.S. FDA-approved molecules with another 200 in development, in addition to more than 100 molecules pending approval.

Amneal product pipeline affords broad coverage of therapeutic areas including cardiovascular, central nervous system/pain, oncology, inflammation, anti-infective, dermatology, endocrinology, diabetes, rhinology, urology, and hematology, among others.

Topicals
Respiratory (Inhalation)
Oral Solids
Device Driven
Transdermals
Oral Liquids
Ophthalmic
Injectables